Clinical Study

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease

Figure 2

Kappa/lambda serum FLC ratio in patients with IgG4-RD. Comparison of serum free κ and λ light chains ratio in controls, IgG4-RD patients with active disease (IgG4-RD AD) and nonactive disease (IgG4-RD NA). Median and interquartile ranges are shown.
426759.fig.002